StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > NEVER NO DEALS

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Oct 19, 2022 10:31am

125 Views

Post# 35033562

RE:NEVER NO DEALS

frewil11 wrote: I can't believe with Aristotle they never announce any deals with anyone , something is not right here .

What are you talking about?

They signed a massive $20M with Oncore (aka the company they invented) which in turn signed a epic deal with "iBodyCheck" of $60M. You know that company in "euorpe" with no stores, no company headquarters, no contact of any kind.

Just look at everything that happend with that. Oh but we can blame the covid on that. $80M in total and not one cent was ever made.

Who here tried calling Oncore back in the day! haha

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading